LBD
HZNP

Landsberg Bennett & Dubbaneh’s Horizon Therapeutics Public Limited Company Ordinary Shares HZNP Stock Holding History

Landsberg Bennett & Dubbaneh’s Portfolio HZNP Stock Details HZNP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		$1.29M Sell
11,784
-1,127
-9% -$117K 0.17% 116
2021
Q2 		$1.23M Buy
12,911
+488
+4% +$44.9K 0.16% 117
2021
Q1 		$1.12M Buy
12,423
+3,841
+45% +$324K 0.16% 113
2020
Q4 		$628K Buy
+8,582
New +$638K 0.1% 128

Other funds holding HZNP

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return
PC
Paulson & Co New York $3.11B AUM 94.93% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Landsberg Bennett & Dubbaneh's HZNP Position: Q3 2021 in Review

Landsberg Bennett & Dubbaneh reduced its Horizon Therapeutics Public Limited Company Ordinary Shares (HZNP) stake by 8.7% in Q3 2021, selling an estimated $117K and leaving 11,784 shares worth $1.29M. The position accounts for 0.17% of the portfolio, ranked #116.

Landsberg Bennett & Dubbaneh first reported a position in HZNP in Q4 2020 and has held it in 4 quarters since. 572 funds tracked by Wall St. Rank hold HZNP as of Q3 2021.

  • Landsberg Bennett & Dubbaneh held 11,784 shares of Horizon Therapeutics Public Limited Company Ordinary Shares worth $1.29M as of Q3 2021.
  • Landsberg Bennett & Dubbaneh sold 1,127 Horizon Therapeutics Public Limited Company Ordinary Shares shares in Q3 2021, an estimated $117K.
  • Horizon Therapeutics Public Limited Company Ordinary Shares made up 0.17% of Landsberg Bennett & Dubbaneh's portfolio in Q3 2021, its #116 holding.
  • Landsberg Bennett & Dubbaneh first reported a position in Horizon Therapeutics Public Limited Company Ordinary Shares in Q4 2020 and has held it in 4 quarters since.
  • 572 funds tracked by Wall St. Rank held Horizon Therapeutics Public Limited Company Ordinary Shares as of Q3 2021.

Based on Landsberg Bennett & Dubbaneh's 13F filing for Q3 2021, filed 29 Oct 2021.